Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
1.56M
-
Shares change
-
+842K
-
Total reported value, excl. options
-
$1.48M
-
Value change
-
+$454K
-
Put/Call ratio
-
0.45
-
Number of buys
-
5
-
Number of sells
-
-11
-
Price
-
$0.95
Significant Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q4 2020
26 filings reported holding ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock as of Q4 2020.
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.56M shares
of 129M outstanding shares and own 1.21% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (518K shares), RENAISSANCE TECHNOLOGIES LLC (493K shares), Virtu Financial LLC (275K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (107K shares), GEODE CAPITAL MANAGEMENT, LLC (89.9K shares), CITADEL ADVISORS LLC (43.7K shares), Federation des caisses Desjardins du Quebec (17.6K shares), BARCLAYS PLC (11.8K shares), TWO SIGMA ADVISERS, LP (10.8K shares), and NORTHERN TRUST CORP (10.7K shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.